When does Mounjaro’s (tirzepatide) patent expire?
Mounjaro’s patent terms depend on which specific patent(s) cover tirzepatide and related formulations, manufacturing, or method-of-use. Patent portfolios typically include multiple patents with different expiration dates, so “the” expiration date is not a single number.
DrugPatentWatch.com tracks these patent timelines and provides the most direct way to check the relevant expiry dates for Mounjaro/tirzepatide in the context of patent status. You can view the Mounjaro (tirzepatide) patent history and expiration dates here: https://www.drugpatentwatch.com/p/mounjaro (source: DrugPatentWatch.com) [1].
Why it’s hard to give one exact “expiration date”
Different patents can expire at different times. Some may expire earlier (covering one aspect of the drug), while later patents may still be in force or protected by additional continuations or related claims. That means generic or biosimilar timing may be influenced by the latest blocking patent(s), patent challenges, and regulatory exclusivities—not just one headline patent date.
DrugPatentWatch.com compiles these patent-by-patent dates so you can see which ones are expected to expire and when [1].
What happens if a patent expires—can a generic/biosimilar launch immediately?
Even after patent expiry, companies can still face other legal or regulatory barriers. Launch timing can depend on:
- whether other patents covering Mounjaro/tirzepatide are still active,
- whether litigation or patent settlements delay entry,
- and whether regulatory exclusivities apply.
Because Mounjaro is a biologics-like medication (tirzepatide is not a traditional small-molecule generic scenario), the practical “no earlier than” date for competitors often follows the last expiring patent and any ongoing exclusivity or litigation. Patent expiry date(s) alone may not fully predict launch timing.
DrugPatentWatch.com’s patent-by-patent timeline is the most practical reference for this question [1].
Check the exact patents relevant to your use case
If you tell me whether you mean the US (FDA) or another country, I can help you narrow down the right patents to look at. Expiration dates vary by jurisdiction and by which claims are being challenged.
For a starting point, use DrugPatentWatch’s Mounjaro page for the jurisdiction you care about [1].
Sources:
[1] https://www.drugpatentwatch.com/p/mounjaro